Review of Cipla Indore USFDA 483 Observations
13:33
Review INTAS PHARMA || USFDA 483 Observations ||May 2023 ||
44:50
Select Science | A New Approach to Balance Minimum Weight and Standard Deviation Determination A&D
8:41
Review of Glenmark GOA Warning Letter
8:58
Ipca Laboratories Indore USFDA 483 Observations
8:27
Jubilant Generics || Dehradoon ||USFDA 483 Observations || August 2022 ||
13:02
Review of INTAS PHARMA 483 Observations
10:02
Top 20 Stability section Interview QUESTION & ANSWERS || Part-1 ||
8:02